AT
Actuate Therapeutics, Inc. Common stock
🇺🇸XNAS.ACTUUnited StatesHealthcare
$1.01USDdown -0.02 (-1.94%)ClosedEnd of day8:30 PM
Price$1.01-0.02 (-1.94%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0050831009
- CUSIP
- Not reported
Company
- Employees
- 12
- Headquarters
- Fort Worth, United States
- CEO
- Mr. Daniel M. Schmitt
Market
- Shares outstanding
- 24M
- Market cap
- $24.25M
Highlights
- Market cap
- $24.25M
- EPS LTM
- -$0.86
- P/E LTM
- -1.79
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$20.45M+17.14%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$19.84M+12.67%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.